What is SION's stock-based comp?

SION (SION) reported stock-based comp of $6.55M in Q1 2026.

How has SION's stock-based comp changed year-over-year?

SION's stock-based comp increased by 212.9% year-over-year, from $2.09M to $6.55M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

SION SION Stock-Based Comp

Stock-Based Comp at other companies

Vertex PharmaceuticalsVRTX

$166.4M+0.2%

AbbVieABBV

$444M+8.3%

Septerna, Inc.SEPN

$6.02M+306%

BioCryst PharmaceuticalsBCRX

$16.03M-25.0%

Denali Therapeutics Inc.DNLI

$23.09M-8.2%

Neurocrine BiosciencesNBIX

$57.2M+8.3%

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's stock-based comp?: SION (SION) reported stock-based comp of $6.55M in Q1 2026.
How has SION's stock-based comp changed year-over-year?: SION's stock-based comp increased by 212.9% year-over-year, from $2.09M to $6.55M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.